Onset within 10- 15 minutes.
Impaired glucose tolerance or impaired fasting glucose screening after ager 40 with family history of diabetes.
No islet cell antibodies.
Intermediate acting.
Humalog (lispro).
Very long acting (glargine/detemir/Lantus)
No peak.
Type I
Duration 4-6 hours.
Type II
Onset usually young.
Used for basal dose.
Type II
Rapid acting.
Very long acting (glargine/lantus/levemir)
Antibodies to insulin.
Short acting (regular/Humulin R/Novolin R)
NPH (Humulin N, Novolin N)
Rapid acting (lispro)
Type I
Decrease in endogenous insulin or increased insulin resistance.
Prediabetes
